TRUFLO 250mcg pressurised inhalation suspension CIPLA
fluticasone propionate Indicated for: asthma; chronic obstructive pulmonary disease
letter T · page 63
fluticasone propionate Indicated for: asthma; chronic obstructive pulmonary disease
dulaglutide Indicated for: type 2 diabetes mellitus
dulaglutide Indicated for: type 2 diabetes mellitus
dulaglutide Indicated for: type 2 diabetes mellitus
dulaglutide Indicated for: type 2 diabetes mellitus
dulaglutide Indicated for: type 2 diabetes mellitus
meningococcal group B vaccine (recombinant, adsorbed) Indicated for: prevention of meningococcal disease
J07AH09 Antiinfectives for systemic use | Bacterial vaccines | Meningococcal vaccines
levetiracetam Indicated for: epilepsy
N03AX14 Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics
levetiracetam Indicated for: epilepsy
N03AX14 Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics
levetiracetam Indicated for: epilepsy
N03AX14 Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics
levetiracetam Indicated for: epilepsy
N03AX14 Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics
levetiracetam Indicated for: epilepsy
N03AX14 Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics
capivasertib Indicated for: breast cancer
capivasertib Indicated for: breast cancer
dorzolamide Indicated for: glaucoma; ocular hypertension
S01EC03 Sensory organs | Antiglaucoma preparations and miotics | Carbonic anhydrase inhibitors
dorzolamide Indicated for: glaucoma; ocular hypertension
S01EC03 Sensory organs | Antiglaucoma preparations and miotics | Carbonic anhydrase inhibitors
emtricitabine + tenofovir Indicated for: HIV-1 infection
rituximab Indicated for: hematologic malignancies
rituximab Indicated for: hematologic malignancies
olezarsen Indicated for: dyslipidemia